MONTELUKAST KERN PHARMA 10 mg FILM-COATED TABLETS
Ask a doctor about a prescription for MONTELUKAST KERN PHARMA 10 mg FILM-COATED TABLETS
How to use MONTELUKAST KERN PHARMA 10 mg FILM-COATED TABLETS
Introduction
Package Leaflet: Information for the User
Montelukast KERN PHARMA 10 mg film-coated tablets EFG
Read all of this leaflet carefully before you start taking this medicine.
- Keep this leaflet, you may need to read it again.
- If you have any further questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you only. Do not pass it on to others, as it may harm them, even if their symptoms are the same as yours.
- If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.
Contents of the pack:
- What is Montelukast Kern Pharma and what is it used for
- Before taking Montelukast Kern Pharma
- How to take Montelukast Kern Pharma
- Possible side effects
- Storage of Montelukast Kern Pharma
- Further information
1. What is MONTELUKAST KERN PHARMA and what is it used for
Montelukast Kern Pharma is a leukotriene receptor antagonist that blocks substances called leukotrienes. Leukotrienes cause narrowing and swelling of the airways in the lungs and can also cause allergy symptoms. By blocking leukotrienes, montelukast improves asthma symptoms, helps control asthma, and improves symptoms of seasonal allergies (also known as hay fever or allergic rhinitis).
Your doctor has prescribed Montelukast Kern Pharma to treat asthma and prevent asthma symptoms during the day and night.
- Montelukast is used for the treatment of patients who are not adequately controlled with their medication and need additional treatment.
- Montelukast also helps prevent airway narrowing caused by exercise.
- In asthmatic patients for whom montelukast is indicated for asthma, montelukast may also provide symptomatic relief of seasonal allergic rhinitis.
Depending on your symptoms and the severity of your asthma, your doctor will determine how you should use Montelukast Kern Pharma.
What is asthma?
Asthma is a chronic disease.
Asthma includes:
- difficulty breathing due to narrowing of the airways. This narrowing of the airways worsens and improves in response to various diseases.
- airways that are sensitive to many things, such as cigarette smoke, pollen, cold air, or exercise.
- swelling (inflammation) of the inner lining of the airways.
The symptoms of asthma include: Cough, wheezing, and chest congestion.
What are seasonal allergies?
Seasonal allergies (also known as hay fever or allergic rhinitis) are an allergic reaction often caused by airborne pollen from trees, grass, and weeds. Symptoms of seasonal allergies typically include: stuffy nose, runny nose; sneezing; itchy, watery, swollen, red, and stinging eyes.
2. BEFORE TAKING MONTELUKAST KERN PHARMA
Tell your doctor about any allergy or medical problem you have now or have had.
Do not take Montelukast Kern Pharma if you
- are allergic (hypersensitive) to montelukast or any of the other ingredients of Montelukast Kern Pharma (see 6. FURTHER INFORMATION).
Be careful with Montelukast Kern Pharma
- If your asthma or breathing worsens, tell your doctor immediately.
- Oral montelukast is not indicated for the treatment of acute asthma attacks. If an attack occurs, follow the instructions given by your doctor. Always have your rescue inhaler medication for asthma attacks.
- It is essential that you or your child use all asthma medications prescribed by your doctor. Montelukast Kern Pharma should not replace other asthma medications prescribed by your doctor.
- Any patient being treated with asthma medications should be aware that if they develop a combination of symptoms such as flu-like illness, tingling or numbness of arms or legs, worsening of lung symptoms, and/or skin rash, they should consult their doctor.
- Do not take acetylsalicylic acid (aspirin) or anti-inflammatory medications (also known as non-steroidal anti-inflammatory drugs or NSAIDs) if they worsen your asthma.
Several neuropsychiatric events (such as changes in behavior and mood-related changes, depression, and suicidal tendencies) have been reported in patients of all ages treated with montelukast (see section 4). If you develop these symptoms while taking montelukast, you should contact your doctor. |
Use in children
For children aged 2 to 5 years, Montelukast Kern Pharma 4 mg chewable tablets are available.
For children aged 6 to 14 years, Montelukast Kern Pharma 5 mg chewable tablets are available.
Use of other medications
Some medications may affect the functioning of Montelukast, or Montelukast may affect the functioning of other medications you are using.
Tell your doctor or pharmacist if you are using or have recently used other medications, including those purchased without a prescription.
Before taking Montelukast Kern Pharma, tell your doctor if you are taking the following medications:
- phenobarbital (used to treat epilepsy)
- phenytoin (used to treat epilepsy)
- rifampicin (used to treat tuberculosis and some other infections)
Taking Montelukast Kern Pharma with food and drinks
Montelukast Kern Pharma can be taken with or without food.
Pregnancy and breastfeeding
Use during pregnancy
Women who are pregnant or plan to become pregnant should consult their doctor before taking Montelukast Kern Pharma. Your doctor will assess whether you can take montelukast during this period.
Use during breastfeeding
It is unknown whether montelukast appears in breast milk. If you are breastfeeding or plan to breastfeed, you should consult your doctor before taking Montelukast Kern Pharma.
Driving and using machines
Montelukast Kern Pharma is not expected to affect your ability to drive a car or operate machinery. However, individual responses to the medication may vary. Certain side effects (such as dizziness and drowsiness) that have been reported very rarely with montelukast may affect the patient's ability to drive or operate machinery.
Important information about some of the ingredients of Montelukast Kern Pharma
The film-coated tablets of Montelukast Kern Pharma contain lactose. If your doctor has told you that you have an intolerance to some sugars, consult your doctor before taking this medication.
3. HOW TO TAKE MONTELUKAST KERN PHARMA
- You should only take one Montelukast Kern Pharma tablet once a day, as prescribed by your doctor.
- It should be taken even when you do not have symptoms or when you have an acute asthma attack.
- Always take Montelukast Kern Pharma as your doctor has told you. Consult your doctor or pharmacist if you are unsure.
- It should be taken orally.
For adults aged 15 years and older:
One 10 mg tablet should be taken daily in the evening. Montelukast can be taken with or without food.
If you are taking Montelukast, make sure you do not take any other medication that contains the same active ingredient, montelukast.
If you take more Montelukast Kern Pharma than you should
Seek immediate medical attention from your doctor.
In most cases of overdose, no side effects were reported. The symptoms that occurred most frequently in overdose in adults and children were abdominal pain, drowsiness, thirst, headache, vomiting, and hyperactivity.
If you forget to take Montelukast Kern Pharma
Try to take Montelukast as prescribed. However, if you miss a dose, just resume your regular schedule of one tablet once daily.
Do not take a double dose to make up for forgotten doses.
If you stop taking Montelukast Kern Pharma
Montelukast can only treat your asthma if you continue to take it. It is essential that you continue taking montelukast for as long as your doctor prescribes it. It will help control your asthma.
If you have any further questions about the use of this product, ask your doctor or pharmacist.
4. Possible side effects
Like all medicines, Montelukast Kern Pharma can cause side effects, although not everybody gets them.
In clinical trials conducted with montelukast, the side effects related to the administration of the medication and reported most frequently (occurring in at least 1 in 100 patients and less than 1 in 10 patients treated) were:
- abdominal pain
- headache
These side effects were generally mild and occurred more frequently in patients treated with montelukast than with placebo (a pill that does not contain medication).
Additionally, since the medication has been marketed, the following side effects have been reported:
- upper respiratory infection
- increased risk of bleeding
- allergic reactions including skin rash, swelling of the face, lips, tongue, and/or throat that can cause difficulty breathing or swallowing
- mood-related changes and behavioral changes [sleep disturbances, including nightmares, hallucinations, irritability, feeling anxious, restlessness, excitement including aggressive or hostile behavior, tremor, depression, sleep problems, sleepwalking, suicidal thoughts and actions (in very rare cases)]
- dizziness, drowsiness, tingling/numbness, seizures
- palpitations
- nosebleeds
- diarrhea, dry mouth, indigestion, nausea, vomiting
- hepatitis (inflammation of the liver)
- bruises, itching, hives, red painful bumps under the skin that occur most frequently on the shins (erythema nodosum)
- joint or muscle pain, muscle cramps
- fatigue, discomfort, swelling, fever
- stuttering (very rare - may affect up to 1 in 10,000 people).
In asthmatic patients treated with montelukast, very rare cases of a combination of symptoms such as flu-like illness, tingling or numbness of arms and legs, worsening of lung symptoms, and/or skin rash (Churg-Strauss syndrome) have been reported. You should immediately inform your doctor if you have one or more of these symptoms.
Ask your doctor or pharmacist for more information about side effects. If you experience any side effects not listed in this leaflet, or if you experience any side effect that is severe or worsening, tell your doctor or pharmacist.
5. Storage of MONTELUKAST KERN PHARMA
- Keep out of the reach and sight of children.
- Do not use this medication after the expiration date stated on the packaging after EXP. The expiration date is the last day of the month indicated.
- Medicines should not be disposed of via wastewater or household waste. Return the packaging and any unused medication to the pharmacy's SIGRE collection point. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medication. This will help protect the environment.
6. FURTHER INFORMATION
Composition of Montelukast Kern Pharma
- The active ingredient is montelukast. Each film-coated tablet contains 10.4 mg of montelukast sodium, equivalent to 10 mg of montelukast.
- The other ingredients are: lactose monohydrate, microcrystalline cellulose, sodium croscarmellose, hydroxypropyl cellulose, magnesium stearate, and Opadry AMB TAN.
Appearance of the product and packaging contents
The film-coated tablets of Montelukast Kern Pharma 10 mg are round, beige, and biconvex.
They are available in packs of 28 tablets.
Marketing authorization holder
KERN PHARMA, S.L.
Venus, 72 - Polígono Ind. Colón II
08228 Terrassa (Barcelona)
Spain
Manufacturer
PHARMATHEN S.A.
Dervenakion 6
Pallini 15351
Attikis (Greece)
This leaflet was approved in May 2024
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
How much does MONTELUKAST KERN PHARMA 10 mg FILM-COATED TABLETS cost in Spain ( 2025)?
The average price of MONTELUKAST KERN PHARMA 10 mg FILM-COATED TABLETS in November, 2025 is around 21.06 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
- Country of registration
- Average pharmacy price21.06 EUR
- Active substance
- Prescription requiredYes
- Manufacturer
- This information is for reference only and does not constitute medical advice. Always consult a licensed doctor before taking any medication. Oladoctor is not responsible for medical decisions based on this content.
- Alternatives to MONTELUKAST KERN PHARMA 10 mg FILM-COATED TABLETSDosage form: TABLET, 10 mgActive substance: montelukastManufacturer: Krka D.D. Novo MestoPrescription requiredDosage form: CHEWABLE TABLET, 4 mgActive substance: montelukastManufacturer: Krka D.D. Novo MestoPrescription requiredDosage form: CHEWABLE TABLET, 5 mgActive substance: montelukastManufacturer: Krka D.D. Novo MestoPrescription required
Alternatives to MONTELUKAST KERN PHARMA 10 mg FILM-COATED TABLETS in other countries
The best alternatives with the same active ingredient and therapeutic effect.
Alternative to MONTELUKAST KERN PHARMA 10 mg FILM-COATED TABLETS in Poland
Alternative to MONTELUKAST KERN PHARMA 10 mg FILM-COATED TABLETS in Ukraine
Online doctors for MONTELUKAST KERN PHARMA 10 mg FILM-COATED TABLETS
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for MONTELUKAST KERN PHARMA 10 mg FILM-COATED TABLETS – subject to medical assessment and local rules.
Get updates and exclusive offers
Be the first to know about new services, marketplace updates, and subscriber-only promos.
